ELIZABETH STULLER: Open Payments
NPI 1326177718 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,267 in 64 payments from 11 companies in 2025. Trend: 2023 $13,278 · 2024 $14,786 · 2025 $2,267
Food & beverage: $1,259Honoraria: $1,000Education: $8
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 8 | $1,153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $219 |
| Vanda Pharmaceuticals Inc. | 7 | $178 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $175 |
| ABBVIE INC. | 10 | $175 |
| Lundbeck LLC | 4 | $94 |
| Teva Pharmaceuticals USA, Inc. | 5 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $74 |
| Corium, LLC | 2 | $45 |
| Alkermes, Inc. | 2 | $42 |
Products named: Sunosi, TRINTELLIX, CAPLYTA, VRAYLAR, FANAPT, REXULTI, Auvelity, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
